E-LIB Suche - Ergebnisse für: Amboldi, N.

1

NMS-P088, a CSF-1R, FLT3 and KIT inhibitor with outstanding..:

Ardini, E. ; Lombardi Borgia, A. ; Texido, G....
European Journal of Cancer. 69 (2016) - p. S127-S128 , 2016

Link: https://doi.org/10.1016/..

2

517 Identification and characterization of selective MELK k..:

Carpinelli, P. ; Amboldi, N. ; Ballinari, D....
European Journal of Cancer. 50 (2014) - p. 168 , 2014

Link: https://doi.org/10.1016/..

3

Anti‐tumour efficacy on glioma models of PHA‐848125, a mult..:

Albanese, C ; Alzani, R ; Amboldi, N...
British Journal of Pharmacology. 169 (2013) 1 - p. 156-166 , 2013

Link: https://doi.org/10.1111/..

4

544 Characterization of Potent and Well Tolerated Second Ge..:

Ciomei, M. ; Amboldi, N. ; Cribioli, S....
European Journal of Cancer. 48 (2012) - p. 167 , 2012

Link: https://doi.org/10.1016/..

5

309 Characterization of a Novel, Highly Potent and Selectiv..:

Ardini, E. ; Amboldi, N. ; Avanzi, N....
European Journal of Cancer. 48 (2012) - p. 94-95 , 2012

Link: https://doi.org/10.1016/..

6

102 Identification and preclinical characterization of NMS-..:

Ardini, E. ; Borgia, A. Lombardi ; Ponti, C. De...
European Journal of Cancer Supplements. 8 (2010) 7 - p. 39-40 , 2010

Link: https://doi.org/10.1016/..

7

170 NMS-E628, a potent and orally available small molecule ..:

Ardini, E. ; Menichincheri, M. ; Magnaghi, P....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 59 , 2010

Link: https://doi.org/10.1016/..

8

147 Pharmacological characterization of NMS-P506, a novel s..:

Fogliatto, G. ; Mantegani, S. ; Amboldi, N....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 52 , 2010

Link: https://doi.org/10.1016/..

9

294 POSTER Biological characterization of the dual CDK2/TRK..:

Alzani, R. ; Albanese, C. ; Locatelli, G....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 94-95 , 2008

Link: https://doi.org/10.1016/..

10

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubici..:

Merlini, G ; Ascari, E ; Amboldi, N...
Proceedings of the National Academy of Sciences. 92 (1995) 7 - p. 2959-2963 , 1995

Link: https://doi.org/10.1073/..

11

Anti-tumour efficacy on glioma models of PHA-848125, a mult..:

Albanese, C ; Alzani, R ; Amboldi, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2013

Link: http://www.ncbi.nlm.nih...

12

The polo-like kinase 1 (PLK1) inhibitor NMS-P937 is effecti..:

Casolaro, A ; Golay, J ; Albanese, C...
https://eprints.gla.ac.uk/80547/1/80547.pdf. , 2013

Link: https://eprints.gla.ac.u..

13

Delivery of methoxymorpholinyl doxorubicin by interleukin 2..:

Quintieri, L ; Rosato, A ; Amboldi, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362260. , 1999

Link: http://www.ncbi.nlm.nih...

14

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubici..:

Merlini, G ; Ascari, E ; Amboldi, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC42338. , 1995

Link: http://www.ncbi.nlm.nih...